# Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)

> **NCT01275092** · PHASE2 · COMPLETED · sponsor: **Corindus Inc.** · enrollment: 164 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Disease
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Vascular Diseases

## Interventions

- **DEVICE:** CorPath robotic-assisted PCI

## Key facts

- **NCT ID:** NCT01275092
- **Lead sponsor:** Corindus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2012-01
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2013-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01275092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01275092, "Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01275092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*